Ewing Sarcoma Clinical Trials 2022
Browse 37 Ewing Sarcoma Medical Studies Across 176 Cities
3 Phase 3 Trial · 657 Ewing Sarcoma Clinics
Reviewed by Michael Gill, B. Sc.
25 Ewing Sarcoma Clinical Trials Near Me
Top Hospitals for Ewing Sarcoma Clinical Trials
Children's Hospital Los Angeles
Los Angeles
8Active Trials
33All Time Trials for Ewing Sarcoma
2001First Ewing Sarcoma Trial
Cincinnati Children's Hospital Medical Center
Cincinnati
7Active Trials
34All Time Trials for Ewing Sarcoma
2001First Ewing Sarcoma Trial
Dana-Farber Cancer Institute
Boston
7Active Trials
31All Time Trials for Ewing Sarcoma
1996First Ewing Sarcoma Trial
Johns Hopkins All Children's Hospital
Saint Petersburg
7Active Trials
23All Time Trials for Ewing Sarcoma
2007First Ewing Sarcoma Trial
Top Cities for Ewing Sarcoma Clinical Trials
Ewing Sarcoma Clinical Trials by Phase of Trial
Phase 1 Ewing Sarcoma Clinical Trials
15Active Ewing Sarcoma Clinical Trials
15Number of Unique Treatments
73Number of Active Locations
Ewing Sarcoma Clinical Trials by Age Group
18+ Ewing Sarcoma Clinical Trials
4Active Ewing Sarcoma Clinical Trials
Most Recent Ewing Sarcoma Clinical Trials
Clinical Trial
Began Recruiting Date
Phase
Top Treatments for Ewing Sarcoma Clinical Trials
Recently Completed Studies with FDA Approved Treatments for Ewing Sarcoma Treatment Name
Active Ewing Sarcoma Clinical Trials
All Time Trials for Ewing Sarcoma
First Recorded Ewing Sarcoma Trial
Palbociclib
2
4
2017
Irinotecan
2
12
2011
Seclidemstat
2
2
2018
Phase 1 Dose Escalation
1
1
2022
Abemaciclib
1
2
2016
Treatment
Year
Sponsor
Nivolumab
2021
Bristol-Myers Squibb
Eribulin mesylate
2018
Eisai Inc.
About The Author
Michael Gill - B. Sc.
First Published: October 9th, 2021
Last Reviewed: November 10th, 2022
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.
Relevant Clinical Trials
Top Oncology Trials
Popular Clinical Trials
References1 Hattinger CM, Patrizio MP, Magagnoli F, Luppi S, Serra M. An update on emerging drugs in osteosarcoma: towards tailored therapies? Expert Opin Emerg Drugs. 2019 Sep;24(3):153-171. doi: 10.1080/14728214.2019.1654455. Epub 2019 Aug 14. Review. https://pubmed.ncbi.nlm.nih.gov/314019032 Senzer N, Barve M, Kuhn J, Melnyk A, Beitsch P, Lazar M, Lifshitz S, Magee M, Oh J, Mill SW, Bedell C, Higgs C, Kumar P, Yu Y, Norvell F, Phalon C, Taquet N, Rao DD, Wang Z, Jay CM, Pappen BO, Wallraven G, Brunicardi FC, Shanahan DM, Maples PB, Nemunaitis J. Phase I trial of "bi-shRNAi(furin)/GMCSF DNA/autologous tumor cell" vaccine (FANG) in advanced cancer. Mol Ther. 2012 Mar;20(3):679-86. doi: 10.1038/mt.2011.269. Epub 2011 Dec 20. https://pubmed.ncbi.nlm.nih.gov/221867893 Ghisoli M, Barve M, Schneider R, Mennel R, Lenarsky C, Wallraven G, Pappen BO, LaNoue J, Kumar P, Nemunaitis D, Roth A, Nemunaitis J, Whiting S, Senzer N, Fletcher FA, Nemunaitis J. Pilot Trial of FANG Immunotherapy in Ewing's Sarcoma. Mol Ther. 2015 Jun;23(6):1103-1109. doi: 10.1038/mt.2015.43. Epub 2015 Mar 19. https://pubmed.ncbi.nlm.nih.gov/259174594 Ghisoli M, Barve M, Mennel R, Lenarsky C, Horvath S, Wallraven G, Pappen BO, Whiting S, Rao D, Senzer N, Nemunaitis J. Three-year Follow up of GMCSF/bi-shRNA(furin) DNA-transfected Autologous Tumor Immunotherapy (Vigil) in Metastatic Advanced Ewing's Sarcoma. Mol Ther. 2016 Aug;24(8):1478-83. doi: 10.1038/mt.2016.86. Epub 2016 Apr 25. https://pubmed.ncbi.nlm.nih.gov/271096315 Ghisoli M, Rutledge M, Stephens PJ, Mennel R, Barve M, Manley M, Oliai BR, Murphy KM, Manning L, Gutierrez B, Rangadass P, Walker A, Wang Z, Rao D, Adams N, Wallraven G, Senzer N, Nemunaitis J. Case Report: Immune-mediated Complete Response in a Patient With Recurrent Advanced Ewing Sarcoma (EWS) After Vigil Immunotherapy. J Pediatr Hematol Oncol. 2017 May;39(4):e183-e186. doi: 10.1097/MPH.0000000000000822. https://pubmed.ncbi.nlm.nih.gov/283385696 Leavey PJ, Laack NN, Krailo MD, Buxton A, Randall RL, DuBois SG, Reed DR, Grier HE, Hawkins DS, Pawel B, Nadel H, Womer RB, Letson GD, Bernstein M, Brown K, Maciej A, Chuba P, Ahmed AA, Indelicato DJ, Wang D, Marina N, Gorlick R, Janeway KA, Mascarenhas L. Phase III Trial Adding Vincristine-Topotecan-Cyclophosphamide to the Initial Treatment of Patients With Nonmetastatic Ewing Sarcoma: A Children's Oncology Group Report. J Clin Oncol. 2021 Dec 20;39(36):4029-4038. doi: 10.1200/JCO.21.00358. Epub 2021 Oct 15. Erratum in: J Clin Oncol. 2022 Jul 20;40(21):2393. https://pubmed.ncbi.nlm.nih.gov/346529687 Leavey PJ, Laack NN, Krailo MD, Buxton A, Randall RL, DuBois SG, Reed DR, Grier HE, Hawkins DS, Pawel B, Nadel H, Womer RB, Letson GD, Bernstein M, Brown K, Maciej A, Chuba P, Ahmed AA, Indelicato DJ, Wang D, Marina N, Gorlick R, Janeway KA, Mascarenhas L. Phase III Trial Adding Vincristine-Topotecan-Cyclophosphamide to the Initial Treatment of Patients With Nonmetastatic Ewing Sarcoma: A Children's Oncology Group Report. J Clin Oncol. 2021 Dec 20;39(36):4029-4038. doi: 10.1200/JCO.21.00358. Epub 2021 Oct 15. https://pubmed.ncbi.nlm.nih.gov/34652968
Unbiased Results
We believe in providing patients with all the options.Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.Back to top
Conditions
Cancer Related
Treatments